BUY D’OXYVA

Wound Care Solution

Clinical studies with D’OXYVA® (deoxyhemoglobin vasodilator) have shown* extraordinary results for the role of transdermal non-invasive wound care using ultra-purified, non-toxic FDA-cleared molecules, such as CO2, especially when all other approaches failed.

In an ongoing multi-year, multi-country, multi-center, randomized clinical trial on patients with diabetic foot ulcers, D’OXYVA has demonstrated speeding up diabetic wound healing and ultimately wound closure to an average of 5 weeks**.

In addition, D’OXYVA eliminated pain and improved quality of life such as sleep, appetite and mood in just a week in 100% of subjects. No adverse events of any kind were reported during, and years after the studies.

The following images illustrate the typical example of D’OXYVA’s efficacy as a stand-alone non-invasive wound care solution for closing chronic vascular disease-related wounds.



All other advanced and traditional modalities have failed after a year of expert intervention at a leading military hospital. A 5-minute (16g CO2) D’OXYVA was applied twice a day on a thumb and on the wound for a total of 4 weeks and healing continued long after.


Patients and physicians report quicker, more comfortable diabetic wound treatment, wound closure, and overall recovery from trauma, and so-called non-healing chronic wounds related to diabetes and cardiovascular complications.***

          BUY D’OXYVA


Take two 16g cartridges each day, in the morning and at night for the first month. Measure your results of blood flow and wound healing then adjust dosing accordingly to one per day in the second month.For maintenance after complete healing, take two or three 16g cartridges each week for as long as you can to avoid the reoccurrence of wounds. Engage in light exercise such as swimming, stretching, walking, meditation, yoga and the like to improve results.Want a customized treatment plan? Contact us now >>


Over two dozen clinical studies demonstrated outsized results at clinics and at home with zero adverse events. For example, D’OXYVA® (deoxyhemoglobin vasodilator) has been recording significant results also as a varicose vein treatment while delivering major clinical outcomes for well over 90% of users. Average results rounded for display, based on number of enrolled subjects in each clinical study with D’OXYVA and user feedback.
Read D’OXYVA Clinical Evidence >>

Ask your doctor before taking D’OXYVA. For prescription for medical use. Read D’OXYVA Regulatory Statements >>

We will refund your entire D’OXYVA purchase price if you do not achieve any improvements (proof of purchase required, improvements of blood flow (perfusion index) measured from absolute baseline without taking D’OXYVA).
Read Circularity’s Return Policy >>